ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint744,962 companies indexed · Last updated: today
DirectoryFinance & InsuranceHolding CompaniesBaselBeOne Medicines AG
BeOne Medicines AG Logo
Verified· 2 sources

BeOne Medicines AG

Summary

About the company

BeOne Medicines AG develops cancer medicines and conducts research and clinical development in oncology, focusing on targeted therapies for hematologic malignancies and solid tumors. The company advances a pipeline of investigational therapies, runs global clinical trials and collaborates on development, manufacturing and patient access.

AI-generated
Offering

Products & services

Industry:Holding Companies
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered
9
Cancer medicines
Cancer medicines, including BRUKINSA (zanubrutinib), TEVIMBRA (tislelizumab-jsgr) and BEQALZI (sonrotoclax).
Clinical trials
Clinical trials in haematology, lung cancer, stomach cancer, breast cancer and other indications; opportunities to participate and obtain information for patients and healthcare professionals.
Research and development
Research and development for oncology therapies with a focus on haematology and solid tumours, as well as approaches such as CDACs and antibody drug conjugates.
Patient Support Program
Personalised support for prescribed patients, including insurance and co-pay assistance, education and help with financial, advisory and transportation needs.
Expanded Access Program
Access to investigational products for patients with no other treatment options and not participating in a clinical trial, in compliance with local regulations.
Partnerships for development, manufacturing and access
Partnerships with biotech, pharma and academic partners for process design, manufacturing, regulatory strategy, global clinical trials and market access.
Manufacturing of medicines
Manufacturing of small molecules, biologics, antibody drug conjugates, oral dosage forms and injectables, as well as analytical and process development.
Treatment of haematological malignancies
Treatment of B-cell disorders and other haematological malignancies with agents such as Zanubrutinib, Sonrotoclax and Blinatumomab in the pipeline or approved.
Treatment of solid tumours
Treatment of solid tumours, including lung, gastrointestinal, breast and gynaecological cancers, with approved and development-stage agents.
Comparisons

BeOne Medicines AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank BeOne Medicines AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of BeOne Medicines AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Aeschengraben 27
4051 Basel

At a glance

Legal form
Corporation
UID
CHE-446.472.541
Founded
2025 · 1 year
Last commercial register change
August 6, 2026
Employees
21 to 50

Knowledge

No knowledge articles yet

Once BeOne Medicines AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

FS
Fruselva Suisse AG
Basel
SR
Swiss Rockets AG
Basel
SH
Straumann Holding AG
Basel
KI
Kuboid Invest AG
Basel
AC
Applied Chemicals International Group AG
Basel
HA
HANAKU AG
Basel
WS
Warteck Sport Holding AG
Basel
RA
RhyVest AG
Basel